Skip to main content

Medicare could save billions if allowed to negotiate insulin prices

By U.S. News & World Report  
   February 05, 2020

If you don't need insulin, you probably haven't paid much attention to its skyrocketing cost, but new research shows that exorbitant drug pricing eventually affects everyone.

Full story

Get the latest on healthcare leadership in your inbox.